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ABSTRACT
Mesp family proteins comprise two members named
mesodermal posterior 1 (Mesp1) and mesodermal pos-
terior 2 (Mesp2). Both Mesp1 and Mesp2 are transcrip-
tion factors and they share an almost identical basic
helix-loop-helix motif. They have been shown to play
critical regulating roles in mammalian heart and somite
development. Mesp1 sits in the core of the complicated
regulatory network for generation of cardiovascular
progenitors while Mesp2 is central for somitogenesis.
Here we summarize the similarities and differences in
their molecular functions during mammalian early
mesodermal development and discuss possible future
research directions for further study of the functions of
Mesp1 and Mesp2. A comprehensive knowledge of
molecular functions of Mesp family proteins will even-
tually help us better understand mammalian heart
development and somitogenesis as well as improve the
production of speciﬁc cell types from pluripotent stem
cells for future regenerative therapies.
KEYWORDS Mesp, transcription factor, pluripotent stem
cells, cardiovascular differentiation, somitogenesis
INTRODUCTION
In humans and mice, Mesp family proteins comprise two
members named mesodermal posterior 1 (Mesp1) and
mesodermal posterior 2 (Mesp2), which have been shown to
play critical roles in embryonic mesodermal development.
Both Mesp proteins are transcription factors and share an
almost identical basic helix-loop-helix (bHLH) motif (Fig. 1).
Mesp1 and Mesp2 genes are located on the same chro-
mosome, head to head, and are separated only by ∼25 kb in
human and ∼16 kb in mouse, respectively. Further, both
Mesp proteins are expressed in the early mesoderm in
embryos, suggesting similar functions in embryonic devel-
opment. However, single gene knockout studies in mice
indicated the two Mesp proteins exhibit considerable func-
tional diversity. Here we discuss the similarities and differ-
ences in the molecular functions of Mesp1 and Mesp2 in
mammalian mesodermal development and possible future
research.
FUNCTIONAL ROLE OF MESP1 IN EMBRYONIC
MESODERMAL DEVELOPMENT
Mesp1 was ﬁrstly identiﬁed in 1996 as a novel bHLH protein
appearing in the mesoderm at the early stage of mouse
gastrulation (Saga et al., 1996). In situ hybridization and
Mesp1 promoter driven beta-galactosidase gene (LacZ)
studies showed that, in mouse embryonic development, the
Mesp1-expressing cells were observed to ingress throughQianqian Liang and Chen Xu have contributed equally to this study.
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the primitive streak and later in a wedge-shaped distribution
in the nascent mesoderm at embryonic day 6.5–7.0 (E6.5–
7.0) (Saga et al., 1999). Its initial expression was promptly
down-regulated with a weaker expression observed in the
presomitic mesoderm and was later observed to localize
only at the base of the allantois at E7.5. Furthermore,
transgenic offspring generated by crossing lacZ reporter
mice with Mesp1-CRE mice indicated that, at E9.5, cells
transiently expressed Mesp1 during development were
mainly observed in the heart, dorsal aorta, intersomitic and
cranial vessels, and the amnion contiguous to the closing
foregut. Cells of all cardiac lineages including the myo-
cardium, the endocardium, the conduction cells, and the
epicardium were all β-Gal-positive (Saga et al., 1999). These
results indicated Mesp1 at least marked the precursors of
multipotent cardiovascular progenitors (MCPs) of both heart
ﬁelds and was required for these precursor cells to depart
from the primitive streak and to generate a single heart tube
(Saga et al., 2000). However, Mesp1 knockout mice exhib-
ited a morphogenetic abnormality in the heart but did not
lead to absence of cardiac and vascular cells (Fig. 2), pos-
sibly due to functional compensation mediated by the mas-
sive up-regulation of its closest homologue Mesp2. In
addition, the Mesp1-null embryo did not disrupt
somitogenesis because of normal expression of the Mesp2
gene (Saga, 1998; Saga et al., 1999). Mesp1 and Mesp2
double-knockout embryo showed a complete defect of
mesodermal migration and heart formation which conﬁrmed
the compensation effect of Mesp2 for Mesp1 (Kitajima et al.,
2000).
The transient nature of Mesp1 expression during mouse
embryonic development makes it difﬁcult to study the
Mesp1-related molecular networks regulating early cardio-
vascular lineage speciﬁcation. Luckily, differentiation of the
pluripotent embryonic stem cells (ESCs) into downstream
cells of the 3 embryonic germ layers, although lacking of
partial in vivo morphogenesis, still provides an important and
reliable in vitro model recapitulating many essential cellular
and molecular events necessary in triggering lineage-
speciﬁc differentiation (Kouskoff et al., 2005; Kattman et al.,
2007; Murry and Keller, 2008). During embryonic develop-
ment, formation of the nascent mesoderm requires the
spatially and temporally regulated expression of genes
involved in the Wnt, BMP, and Nodal pathways (Rossant and
Tam, 2004). These factors participated in the ingress and
migration of epithelial cells in the gastrulating epiblast (via
epithelial-to-mesenchymal transformation (EMT)), and fur-
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Figure 1. Similarities between mouse Mesp1 and Mesp2. (A) Schematic diagram of mouse Mesp1 and Mesp2. The bHLH domain
is colored black. (B) Alignment of mouse Mesp1 and Mesp2 shows that the bHLH domains are almost identical. The alignment was
done using Clustal X. Conserved positions are marked by characters above the alignment: “*” indicates identical residue. “:” shows
that one of the following ‘strongly conserved’ groups: STA, NEQK, NHQK, NDEQ, QHRK, MILV, MILF, HY or FYW. “.” shows that one
of the following ‘weaker conserved’ groups: CSA, ATV, SAG, STNK, STPA, SGND, SNDEQK, NDEQHK, NEQHRK, FVLIM or FYM.
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the nascent mesodermal cells. Subsequent fate restriction of
mesodermal precursors toward cardiovascular and
hematopoietic progenitors was identiﬁed by the expression
of Mesp1 and Flk1 (Wu et al., 2008). It is well-known that the
heart is composed of multiple cell types (including car-
diomyocytes, endothelial cells (ECs), smooth muscle cells,
and cardiac ﬁbroblasts). The cardiac cells were all traced
back to two original sources of MCPs, namely ﬁrst heart ﬁeld
(FHF) and second heart ﬁeld (SHF) progenitors, with an
additional contribution of neural crest cells (Fig. 3) (Bondue
et al., 2011; Buckingham and Desplan, 2010). To track the
earliest Mesp1-expressing cells during ESC differentiation,
Bondue et al. generated Mesp1-GFP reporter ESCs and
showed that these early Mesp1-expressing cells were enri-
ched for MCPs of both heart ﬁelds, which gave rise upon
differentiation to all cardiovascular cell lineages both in vitro
and in vivo. Transcriptional proﬁling following Mesp1 over-
expression demonstrated that Mesp1 rapidly activated many
key genes belonging to the core cardiac transcriptional
machinery (e.g., Hand2, Myocardin, Nkx2-5, Gata4, Mef2c,
Tbx20, and FoxH1), and repressed genes involved in early
primitive streak formation (e.g., Brachyury and FGF8) and
endoderm speciﬁcation (e.g., Foxa2, Gsc, Sox17, Nodal,
and Cer1). Additionally, chromatin immunoprecipitation
experiments showed that Mesp1 directly bound to conserved
E-Box within genomic regions of several upregulated
(Hand2, Myocardin, Nkx2-5, and Gata4) and downregulated
genes (Foxa2, Gsc, Sox17, and Brachyury), suggesting that
Mesp1 directly regulates gene transcription to induce car-
diovascular speciﬁcation and inhibit acquisition of other
possible cell fates during this developmental stage (Bondue
et al., 2008). At the same time, two other groups also
reported that Mesp1 induced cardiovascular differentiation of
ESCs (David et al., 2008; Lindsley et al., 2008). Mesp1 alone
can induce ectopic heart tissue formation in vertebrates
(David et al., 2008). Transient overexpression of Mesp1 is
sufﬁcient to direct ESCs to the cardiac mesoderm while
inhibiting the development of other mesodermal lineages
such as the hematopoietic lineage (Lindsley et al., 2008). A
recent study using the in vitro ESCs differentiation model
provided further evidence that Mesp1 plays a key role in
specifying cardiac development. Surface markers of meso-
dermal progenitor cells PDGFRα, CD13, and ROR2 were
elevated in the Mesp1 promoter-driven mCherry (Mesp1-
mCherry) cells derived from differentiated ESCs, compared
with KDR+ PDGFRα+ cardiac progenitors in which no
enrichment was observed (Den Hartogh et al., 2015).
NKX2.5-eGFP and Troponin T expressing cells were also
up-regulated in the Mesp1-mCherry population and
enhanced by inhibition of the Wnt pathway which conﬁrmed
the potent cardiovascular speciﬁc differentiation. In addition,
Mesp1-mCherry derivatives also contained smooth muscle
cells and endothelial cells (Den Hartogh et al., 2015).
Overall, these dada indicates that Mesp1 plays a central role
in regulating embryonic cardiovascular development and
cardiovascular differentiation of pluripotent stem cells.
Moreover, signiﬁcant effort has been made over the past
two decades for direct reprogramming of ﬁbroblasts into
cardiomyocytes which are required for cardiac regenerative
therapies. Recent studies showed that the efﬁciency for
direct reprogramming of ﬁbroblasts into cardiomyocytes
could be strongly enhanced with the addition of Mesp1 (Islas













Figure 2. Mesp1-null embryos showed defective heart tube
formation and looping. (A) At E9.0, wildtype embryos formed a
single heart tube with normal d-loop. (B) Compared to wildtype
embryos, Mesp1 (−/−) embryos had two separated heart tubes
on either side of the mid-line. Sequential sections through the
heart region clearly revealed normal heart tube looping in E9.0
wildtype embryos (A1–A3) and abnormal structures in E9.5
Mesp1 (−/−) embryos (B1–B3). Also neural fold closure is
defective in Mesp1 (−/−) embryos (B and B1). nt, neural tube; g,
gut; R, right side; L, left side. Adapted from Saga (1998) with
permission.
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enhancing effect for transdifferentiation of ﬁbroblasts to
cardiomyocytes further highlights the central role of Mesp1 in
cardiac cell fate determination.
Some very recent studies, however, challenged the con-
ventional view of the roles of Mesp1 in cardiovascular
development. Chan et al. showed that, in addition to pro-
moting cardiac differentiation, Mesp1 promoted hematopoi-
etic differentiation and skeletal myogenic differentiation of
ESCs in different induction conditions. Lineage tracing
studies in mice also showed that the majority of yolk sac and
certain adult hematopoietic cells were actually derived from
Mesp1+ cells. It is thus proposed that Mesp1 speciﬁes dif-
ferent lineage derivatives in a context-dependent manner
(Chan et al., 2013). This study challenged the previous view
of Mesp1 being a master regulator mostly for specifying
cardiovascular development. Another very recent study also
further clariﬁed a question of whether Mesp1-positive pro-
genitors represent the primitive MCPs common to both FHF
and SHF. Using temporal clonal analysis of Mesp1-ex-
pressing cells, Lescroart et al. provided compelling evidence
that Mesp1 marked distinct classes of cardiovascular pro-
genitors (FHF Mesp1+ progenitors and SHF Mesp1+ pro-
genitors) differentiating into restricted lineages at different
time points during gastrulation. FHF Mesp1+ progenitors
were unipotent and different from the SHF Mesp1+ progen-
itors which were either unipotent or bipotent (Lescroart et al.,
2014). All these data suggested that detailed molecular
processes and the roles of Mesp1 in early cardiovascular
lineage speciﬁcation still require further investigation.
Overall, current research data indicates that the mesoderm
transcription factor Mesp1 seems to situate in the core of the
complicated regulatory network by generating cardiovascular
progenitors and prompting gastrulation development. Mesp1
is transiently expressed in the anterior mesoderm from the
onset of gastrulation prior to cardiac crescent formation.

















Cardiomyocytes Smooth muscle cells Cardiomyocytes Smooth muscle cells Endothelial cells
Figure 3. Hierarchy model of cardiovascular speciﬁcation from pluripotent stem cells. During stem cell differentiation,
Brachyury T expression marks the precardiac mesodermal cells; Mesp1-expressing cells represent early multipotent cardiovascular
progenitors; Nkx2-5 and Islet1 reporter genes are used for isolating cardiovascular progenitors of the ﬁrst (Nkx2-5) and the second
heart ﬁelds (Nkx2-5 and Islet1). Finally, cardiovascular progenitors give rise to all three lineages of the heart: cardiomyocytes,
endothelial cells, and smooth muscle cells.
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the heart including myocardium, endocardium, epicardium,
and cells of the conduction system. Mesp1 directly and/or
indirectly regulated the expression of the majority of key car-
diovascular transcription factors including Hand2, Myocardin,
Nkx2-5, Gata4, Mef2c, Foxc1, and Foxc2, thus acting as a
master regulator and the earliest marker of cardiovascular
development in vertebrates and cardiovascular differentiation
in mammalian pluripotent stem cells.
FUNCTIONAL ROLE OF MESP2 IN EMBRYONIC
MESODERMAL DEVELOPMENT
In 1997, Saga et al. isolated a novel gene encoding bHLH
protein Mesp2, which has an almost identical bHLH motif to
that of Mesp1 (93% amino acid identity) and contains a
unique region at the carboxyl-terminus (Saga et al., 1997). At
E6.5–7.0, Mesp2 was weakly expressed in the early meso-
derm, in a pattern very similar to that of Mesp1 (Kitajima et al.,
2000). Since E8.0, Mesp2 was dynamically expressed in
presomitic mesoderm of mouse embryos, which overlapped
completely with the Mesp1 expression domain (Saga et al.,
1997).
Disruption of the Mesp2 gene in mice impaired segmen-
tation of the somitic mesoderm and resulted in loss of the
rostral properties within the somite (Fig. 4). Consequently,
the Mesp2 knockout mutant pups exhibited fused vertebral
columns and caudal truncation, and died within 20 min after
birth (Saga et al., 1997). Mesp2 gene mutations are also
found in human patients with spondylocostal dysostosis
which is a rare, heritable axial skeleton growth disorder
(Whittock et al., 2004).
Somite formation starts from E8.0 and ends at E13.0 in
mice. During somitogenesis, the presomitic mesoderm is
sequentially subdivided into blocks of cells to form somites.
Prospective segmentation site is deﬁned by Notch oscilla-
tors, while pace of segmentation is regulated by Fgf oscil-
lators (Saga, 2012). Actually the most reliable molecular
marker of segmentation initiation is the transcriptional acti-
vation of Mesp2. Tbx6 and Notch signaling are required for
the induction of Mesp2 expression (Yasuhiko et al., 2006),
while up-regulation of Mesp2 protein in turn leads to the
suppression of Tbx6 expression post-translationally via rapid
protein degradation through the ubiquitin-proteasome path-
way. Therefore the expression of Mesp2 is tightly regulated
by a negative feedback loop in vivo (Oginuma et al., 2008).
Activation of Notch signaling during somitogenesis can be
visualized by immunohistochemistry using a speciﬁc anti-
body to the processed Notch intracellular domain (NICD). At
the initial phase of Mesp2 expression in somitogenesis,
Mesp2 exhibited a partially co-expressing pattern with NICD
as reﬂected by double immunohistochemistry (Morimoto
et al., 2005). Mesp2 suppressed itself through a feedback
loop and suppressed Notch activity by destabilizing
Mastermind-like 1 (MamL1), one of the core components of
the nuclear NICD complex, at the post-transcriptional level
via pathways other than the proteasome pathway (Sasaki
et al., 2011). As expression levels of Mesp2 increase, the
overlapping domain of NICD and Mesp2 gradually reduced.
Ultimately, the caudal half of Mesp2 expression gradually
shrinked, leaving the rostral half band intact. The Mesp2 and
NICD expression domains completely separated from each
other and formed a clear boundary, which produced the next
segmental boundary (Morimoto et al., 2005). Mesp2 also
activated its target genes EphA4, which led to the generation
of the morphological border (Nakajima et al., 2006; Saga,
2007).
Notch signaling activity is also a required determinant of
the caudal identity of the somite. Mesp2 suppressed Notch
activity in the rostral compartment by suppressing Notch
ligand Dll1 and repressed the caudal gene Uncx4.1 to deﬁne
rostral identity (Takahashi et al., 2000). Mesp2 also induced
the expression of Ripply 1 and 2, which in turn played roles
in restricting the expression domain of Mesp2 by suppress-
ing the activity of Tbx6. This negative feedback loop is
essential for the generation of the rostro-caudal polarity
periodically (Takahashi et al., 2010).
A
B
C P1( / ) 
D P1( / ) 
P2( / ) 
(+/+)
Figure 4. Mesp2-null embryos exhibited defective segmen-
tation in somitogenesis. (A) In Mesp2 (−/−) embryos at E9.5,
segmentation of somites is defective, while differentiation into
dermomyotome (DM) proceeds. Compared to wildtype (+/+)
embryos at the same developmental stage (B), Mesp1 (−/−)
embryos showed differentiation into dermomyotome and scle-
rotome with segmentation exhibiting reduced segmental width
(indicated by the width of brackets) (C and D). DM, dermomy-
otome. Bars, 100 μm. Adapted from Saga (1998) with
permission.
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Figure 5. The Mesp1/Mesp2 double-knockout embryos exhibited defective development of the embryonic mesoderm. (A) At
E7.5, in Mesp1/Mesp2 double-knockout embryo, no clear mesodermal cell layer is observed between endodermal and ectodermal
layers; dense cell accumulated in primitive streak and many mesodermal cells accumulated in extraembryonic region. (B) Similarly, at
E8.5, although heart tube and mesenchymal cells in the headfold are developed in the wildtype embryo, mesodermal cells are still not
migrated in the Mesp1/Mesp2 double-knockout embryos. (C) E9.0–9.5 mutant embryos show extensive pile-up of cell layers in the
extraembryonic region and smaller embryonic region with no trunk structure such as the heart, somites or gut developed. exm,
extraembryonic mesoderm; end, endoderm; ect, ectoderm; me, embryonic mesoderm; ps, primitive streak; hf, headfold; ht, heart; en,
endothelial cells. Scale bars, 100 μm. Adapted from Kitajima et al. (2000) with permission.
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In summary, Mesp2 is required for the normal segmen-
tation of somites and generation of the rostro-caudal polarity
of somites.
FUNCTIONAL REDUNDANCY OF MESP1 AND
MESP2 IN EMBRYONIC MESODERMAL
DEVELOPMENT
Segmented somites were detected in Mesp1 deﬁcient
embryos, indicating that Mesp1 was not essential for somi-
togenesis (Takahashi et al., 2005). However, during somi-
togenesis, the Mesp1 gene was also expressed at the same
time and sites as those of Mesp2. Thus, it is speculated that
Mesp1 might play a role in somitogenesis. Furthermore, in
Mesp2 null embryos, there was differentiation into der-
momyotome and sclerotome and delayed irregular seg-
mentation of the dermomyotome without obvious
segmentation in the sclerotome (Fig. 4) (Saga et al., 1997).
Chimera analysis showed Mesp1/Mesp2 double-knockout
cells were not able to undergo epithelialization, whereas
Mesp2 single-knockout cells were integrated into epithelial
somites and dermomyotome occasionally (Takahashi et al.,
2005). Taken together, Mesp1 does contribute to the
epithelialization of dermomyotome observed in Mesp2-null
embryos (Saga et al., 1997).
Overexpression of Mesp1 is sufﬁcient to generate multi-
potent cardiovascular progenitor from ESCs in vitro (Bondue
et al., 2008; David et al., 2008; Lindsley et al., 2008).
Meanwhile, in Mesp2 null mice, no notable developmental
defect was observed prior to somitogenesis, which was
consistent with the low expression level of Mesp2 during the
early gastrulation stage. However, in Mesp1 deﬁciency mice,
mesodermal precursors ﬁnally migrated into the heart ﬁeld,
differentiated and contributed to defective heart morpho-
genesis, while in Mesp1/Mesp2 double-knockout embryos
there was an accumulation of nonmigrating cells in the
primitive streak and complete failure to form cardiac meso-
derm (Fig. 5) (Saga et al., 1999; Kitajima et al., 2000). Mesp2
was weakly expressed at E6.5–7.0 in a pattern very similar
to Mesp1 expression, but expressed longer in Mesp1 (−/−)
embryos compared to wildtype. The initial deﬁciency in
Mesp1 null embryos may be partially rescued by the later
induced and prolonged expression of Mesp2. Studies by
Lindsley et al. further showed that transient expression of
Mesp2 induced expression of EMT genes in DKK treated
cultures (Lindsley et al., 2008). Taken together, Mesp2 can
induce mesoderm and EMT in ESCs, and compensate for
differentiation and migratory defects in Mesp1-deﬁcient
embryos.
In conclusion, Mesp1 and Mesp2 not only have their
respective speciﬁc functions during mammalian cardiac
development and somitogenesis, but also exhibit functional
redundancy in these developmental events.
FUTURE RESEARCH
In addition to genetic approaches, integration of cellular,
molecular, and biochemical methods using both animal and
ESC models will further help elucidate the precise regulatory
mechanisms underlying human heart development and
somitogenesis. Establishing a reliable in vitro developmental
model using human ESCs will be critical for further eluci-
dating the speciﬁc and overlapping roles of Mesp1 and
Mesp2 in early mesodermal development of humans.
Further, it will be important to identify interacting partner
proteins of Mesp1 and Mesp2, which could be able to form a
protein complex together with Mesp1 or Mesp2, functioning
in strict post-translational control or modulating the tran-
scriptional activities by determining speciﬁc target sequen-
ces. A better delineation of the molecular events involving
Mesp1 and Mesp2 will not only contribute to an improved
understanding of mesodermal development, but will also be
helpful to increase the production of speciﬁc cells (e.g. car-
diomyocytes and myoblasts) from the pluripotent stem cells
for future cellular therapy and drug screening.
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